4
Changes in Ownership
OCULAR THERAPEUTIX, INC Filed Acc 0001104659-24-011197
Chief Medical Officer sold 6,346 shares at $4.86 ($30,842)
- Chief Medical Officer acquired 66,633 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Ozden Rabia Gurses · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-02-03 | Grant or award : show line 1 in the form | +66,633 | 159,400 | D | ||
| 2024-02-05 | Sale : show line 2 in the form | +6,346 | $4.86 | $30,842 | 153,054 | D |
| Open-market sales · 6,346 sh · avg $4.86 · $30,842 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-02-03 | Grant or award : show line 3 in the form Stock Option (Right to Buy) | +200,000 | 200,000 | D |
Loading xslF345X05/tm245295-3_4seq1.xml…